JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Appendix 1 - Changes to Donor Selection Guidelines

Section 1

Changes introduced with BM-DSG 203 Release 02 from BM-DSG 202 Release 03


There have been changes made to the following entries:

Acupuncture
Age
Animal Bite
Ankylosing Spondylitis
Anti-Androgens
Antibiotic Therapy
Antidepressant Therapy
Arthritis
Autoimmune Disease
Back Problems
Beta Blockers
Bipolar Disorder
Bleeding Disorder
Blood Pressure - High
Blood Volume Estimation
Cardiovascular Disease
Chikungunya Virus
Chlamydia
Cirrhosis
Colitis
Communication Difficulties
Depression
Dermatitis
Disabled Donor
Disease of Unknown Aetiology
Elliptocytosis
Endocarditis
Endoscopy
Episcleritis
Eye Disease
Gall Bladder Disease
G-CSF
German Measles
Haemoglobin Disorders
Haemolytic Anaemia
Hepatitis B
Hepatitis B - Post Immunization
Hepatitis C
Hepatitis of Unknown Origin
Hereditary Elliptocytosis
Hereditary Spherocytosis
Hormone Replacement Therapy
Immune Thrombocytopenia
Immunoglobulin Therapy
Immunosuppression
Infection - Chronic
Inflammatory Eye Disease
Inoculation Injury
Jaundice
Laminectomy
Latex Allergy
Malaria
Mental Health Problems
Myeloproliferative Syndrome
Pituitary Extract - Human
Platelet Disorder
Polymyalgia Rheumatica
Prion Associated Diseases
Psoriasis
Pyruvate Kinase Deficiency
Rheumatoid Arthritis
Scleritis
Sexually Transmitted Disease
Shingles
Sickle-Cell Trait
Skin Disease
Steroid Therapy
Subacute Bacterial Endocarditis
Surgery
Syphilis
Temporal Arteritis
Thrombocytosis
Thyroid Disease
Tigason
Tissue and Organ Recipients
Transfusion
Weight
West Nile Virus

 

Section 2

Changes to BM-DSG 203 after Release 02


See: Updates

This appendix was last updated in BM-DSG Edition 203, Release 02.

 

Last updated 21/04/2024